Jonathan M. Poole
Board Member
Acadia Pharmaceuticals Inc (ACAD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jonathan M. Poole
Jonathan M. Poole is recorded as Board Member at Acadia Pharmaceuticals Inc (ACAD). Acadia Pharmaceuticals Inc reported in an 8-K filed March 5, 2026 that Jonathan M. Poole was appointed Class II director, effective March 3, 2026.
“On March 3, 2026, the board of directors (the "Board") of Acadia Pharmaceuticals Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Jonathan M. Poole to the Board to fill a vacancy and as a member of the Audit Committee of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-03-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Acadia Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Catherine Owen Adams CEO, Board Member
- Stephen R. Biggar Chairman, Board Member
- Mark C. Schneyer CFO
- Mark Schneyer CFO
- Brendan P. Teehan COO
- Austin D. Kim General Counsel
- James K. Kihara Chief Accounting Officer
- Adora Ndu Board Member
- Adora Ndu, Pharm.D., J.D. Board Member
- Daniel B. Soland Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.